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Abstract
© 2017 Khodzhaeva,  Makeeva,  Ulyanova.  Many ribonucleases  (RNases)  are  considered as
promising tools for antitumor therapy because of their selective cytotoxicity toward cancer cells.
Binase, the RNase from Bacillus pumilus, triggers apoptotic response in cancer cells expressing
RAS oncogene which is mutated in a large percentage of prevalent and deadly malignancies
including colorectal cancer. The specific antitumor effect of binase toward RAS-transformed cells
is due to its direct binding of RAS protein and inhibition of downstream signaling. However, the
delivery of proteins to the intestine is complicated by their degradation in the digestive tract
and subsequent loss of therapeutic activity. Therefore, the search of new systems for effective
delivery of therapeutic proteins is an actual task. This study is aimed to the investigation of
antitumor effect of binase immobilized on natural halloysite nanotubes (HNTs). Here, we have
developed the method of binase immobilization on HNTs and optimized the conditions for the
enzyme loading and release (i); we have found the non-toxic concentration of pure HNTs which
allows  to  distinguish  HNTs-  and  binase-induced  cytotoxic  effects  (ii);  using  dark-field  and
fluorescent  microscopy we have proved the absorption of  binase-loaded HNTs on the cell
surface  (iii)  and  demonstrated  that  binase-halloysite  nanoformulations  possessed  twice
enhanced cytotoxicity toward tumor colon cells as compared to the cytotoxicity of binase itself
(iv).  The  enhanced  antitumor  activity  of  biocompatible  binase-HNTs  complex  confirms  the
advisability of its future development for clinical practice.
http://dx.doi.org/10.3389/fphar.2017.00631
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